What We Listen To

Listen to a16z Podcasts where tech, culture trends, news, and the future are discussed.

Who are the movers and shakers taking the lead at the intersection of biotechnology with business, science, and policy? Veteran journalist Dan Levine knows because he has sat down with countless individuals who have recognized a need in society and have dedicated their lives to finding a solution. These interviews cover everything from the impact of proposed legislation on genetic privacy to presenting a case for calling aging a disease. Tune into this biotech podcast if you are looking for insight on a wide variety of engaging industry topics.

Want to know what has been happening with top pharma and biotech companies in the last week? Tune into STAT’s weekly podcast show with journalists Damian Garde, Adam Feuerstein, and Rebecca Robbins as they rehash the week’s events, give timely shout-outs to The Rock, and throw in a few opportune scandals here and there.

Growth in any field comes from connections, sharing ideas, and questioning the standard quo. There is no one more mindful of this process than Theral Timpson, host and producer of Mendelspod. In this podcast show, Theral and his guest, often the who’s who of the life sciences, focus on a question that reexamines current trends and provides a deeper insight to the things going right and what may need to be improved. Theral’s enthusiasm for learning, discovery, and exploring new ways of looking at the state of the industry keep us coming back to his podcast time and time again.

This is no run of the mill C-suite interview of “tell me what your company does and how it will impact healthcare” podcast show. Instead, Luke Timmerman, an Everest-climbing staple in biotechnology journalism, invites top entrepreneurs who are refreshingly willing to discuss the journey of bringing revolutionary technologies to the world. Luke and his guests wade past the canned responses to discuss the good, the bad, and the crazy needed to make it in this industry.

For a special treat, take a listen to Signal podcast, which Luke hosted with Meg Tirrell for short time in 2016. The two of them did an incredible job at explaining how medicines get made.

Sara Jane Demy, CEO and Founder of Demy-Colton, has spent more than two decades helping biotech CEOs get into the right rooms—and build the relationships that move their companies forward.

In this episode of The Russo Edge Podcast, Sara joins host Solomon Wilcots for a candid conversation about what it takes to lead in today’s capital-constrained biotech environment. She shares why preparation—not just presence—is the key to investor meetings, and what biotech CEOs often get wrong about outreach. Whether you’re a first-time founder or a veteran CEO, this episode offers practical guidance, honest insights, and a look at how the playbook for biotech leadership is being written in real time.